Navigation Links
Molecular Breast Imaging Performs Better Than Ultrasound in Patients With Mammographic Abnormalities
Date:12/1/2008

CHICAGO, Dec. 1 /PRNewswire/ -- For difficult to diagnose patients, Breast-Specific Gamma Imaging (BSGI) is found to be a more useful adjunctive imaging tool than ultrasound for patients who need additional imaging following a questionable mammogram, this according to findings presented today at the annual meeting of the Radiological Society of North America (RSNA). BSGI is a molecular breast imaging technique that can see lesions independent of tissue density and discover very early stage cancers.

"My colleagues and I found that in women who needed further examination beyond mammography in the diagnosis of breast cancer, BSGI offered more definitive answers than ultrasound," said Dr. Jean Weigert, Director of Women's Imaging at Mandell and Blau M.D.'s PC, in New Britain, Conn.

Dr. Weigert conducted a study comparing BSGI to ultrasound in patients who required additional imaging following a mammogram. As part of their diagnostic evaluation, 70 patients had mammography, ultrasound, BSGI and biopsy. BSGI and ultrasound had 96 percent and 58 percent sensitivity respectively and 55 percent and 43 percent specificity respectively. These results demonstrate that BSGI may be more useful than ultrasound as an adjunctive imaging technology to mammography.

BSGI for the study was conducted using a Dilon 6800 Gamma Camera, a high-resolution, small field-of-view gamma camera, optimized to perform BSGI. With BSGI, the patient receives a pharmaceutical tracing agent that is absorbed by all the cells in the body. Due to their increased rate of metabolic activity, cancerous cells in the breast absorb a greater amount of the tracing agent than the normal surrounding tissue and generally appear as "hot spots" on the BSGI image.

Dr. Weigert concluded that, "BSGI provided superior sensitivity and comparable -- if not better -- specificity in this group of patients with questionable mammograms requiring additional diagnostic imaging. BSGI may be a more useful modality than ultrasound as an adjunct imaging technology to mammography."

About Dilon Technologies

Dilon Technologies Inc. is bringing innovative new medical imaging products to market. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform BSGI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; and The Rose, Houston.

For more information on Dilon Technologies please visit http://www.dilon.com.


'/>"/>
SOURCE Dilon Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. A new molecular zip code, and a new drug target for Huntingtons disease
2. New knock-out gene model provides molecular clues to breast cancer
3. Molecular probe paints cancer cells in living animals, Stanford researchers find
4. Story ideas from molecular & cellular proteomics
5. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
6. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
7. Molecular fingerprint of breast-cancer drug resistance can predict response to treatment
8. Molecular profiling can accurately predict survival in colon cancer patients
9. Xceed Molecular Names Fran Tuttle to Its Board of Trustees
10. Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative
11. Xceed Molecular Launches Ziplex(R) Automated Gene-Expression System at the Association for Molecular Pathology, Booth 84/85
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2017)... ... 2017 , ... The quest to develop a cure for HIV has long ... cured? The virus has a knack for lying dormant in immune cells at levels ... University of Pittsburgh’s Graduate School of Public Health announced today in Nature Medicine that ...
(Date:5/28/2017)... ... May 28, 2017 , ... Florida Pain Relief Group, a ... K. Cho, MD, has joined its Winter Haven practice. , Dr. Cho’s ... invasive techniques to treat and manage many types of pain. , Dr. ...
(Date:5/27/2017)... ... May 27, 2017 , ... In any business, follow up is critical to ... dental team at presenting treatment, there will always be some patients who can’t or ... money on best practices when it comes to presenting treatment. After the patient ...
(Date:5/26/2017)... ... 26, 2017 , ... The American Parkinson Disease Association’s ... grant submissions all vying for nearly $1,000,000 in funding that will be awarded ... American Parkinson Disease Association (APDA) is focused on advancing scientific research that will ...
(Date:5/26/2017)... Calif. (PRWEB) , ... May 26, 2017 , ... ... the integration of the CareFusion NOX-T3 portable sleep monitor with its Somnoware Sleep ... a consistent, browser-based interface for diagnostic device operations. With this platform, initializing devices ...
Breaking Medicine News(10 mins):
(Date:5/26/2017)... , May 26, 2017  Endo International plc (NASDAQ: ... President and CEO, will represent the Company in a fireside ... Conference on Tuesday, June 13, 2017 at 10:40 a.m. PT ... Terranea Resort in Rancho Palos Verdes, CA. ... the event will be available on the Company,s website at ...
(Date:5/22/2017)... 22, 2017  Lilac Corp, the company that ... launch of a new website . The ... a clinical study that showed surprising clearance of ... in individuals suffering from HPV warts, precancerous, or ... are no other treatments that clear the virus. ...
(Date:5/15/2017)... , May 15, 2017  Amy Baxter MD, ... industry leader in noninvasive pain relief, was awarded a ... magazine. Baxter was recognized at the MM&M Top ... New York City on May 10, 2017. ... the biopharma industry go "beyond the pill."  ...
Breaking Medicine Technology: